Medical Brands

medicalbrands.com

Imagine all simple diseases could be diagnosed, treated and prevented with self-care products… No more expensive and time-consuming doctor visits and access to the best tools and information to help users manage self-limiting diseases on their own. At Medical Brands, this is how we see the future.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights, PHARMACY MARKET

NOVO NORDISK & ATLATL ANNOUNCE WINNERS IN THEIR JOINT PROGRAM ENTRESTAR

Novo Nordisk & ATLATL | December 06, 2022

news image

Novo Nordisk Research Centre China and ATLATL jointly announce the winners of EntreStar program. Hangzhou DNano MetaBio and Modit Medicine stood out among all participants and won the awards. The two winners will be given priority access to one of ATLATL’s nation-wide facilities in China, and a prize of CNY 500K RMB each to pay for the ATLATL facilities and services. They are also entitled to mentoring by relevant experts of Novo Nordisk. There will be no strings attached fo...

Read More

Business Insights, PHARMACY MARKET

COEUS HOLDINGS ANNOUNCES REBRANDING TO REFLECT THE UNIFICATION OF EACH BUSINESS UNIT INTO ONE ENTITY

Businesswire | May 02, 2023

news image

COEUS, a leading healthcare communications, technology, talent, and consulting firm delivering a variety of services and platforms to all stakeholders in the healthcare ecosystem, announced today that it has completed a major rebranding. Following nearly 14 years of both organic growth and acquisitions, all business units have been combined to form one entity: COEUS. Since the company’s inception in 2009, the company sought to build a suite of services capable of providing...

Read More

MARINUS PHARMACEUTICALS EARNS RARE PEDIATRIC DISEASE DESIGNATION FROM FDA FOR GANAXOLONE TREATING CDKL5 DEFICIENCY DISORDER (CDD)

Marinus Pharmaceuticals | July 31, 2020

news image

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, announced today that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) Designation for the company’s product candidate ganaxolone for the treatment of CDKL5 deficiency disorder (CDD), a rare refractory form of pediatric epilepsy. “We are pleased that ganaxolone has received Rare Pediatric Dis...

Read More

PHARMA TECH

VALGENESIS VLMS TO DRIVE DIGITAL TRANSFORMATION FOR LEADING SPANISH PHARMACEUTICAL COMPANY

PR Newswire | January 03, 2024

news image

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a leading Spanish pharmaceutical company selected ValGenesis VLMS – the industry's most trusted electronic validation lifecycle management system – to digitize its corporate validation process. Founded in Spain over eight decades ago, the company focuses on developing over the counter (OTC) drugs and products. Since then, it has grown its product...

Read More
news image

Business Insights, PHARMACY MARKET

NOVO NORDISK & ATLATL ANNOUNCE WINNERS IN THEIR JOINT PROGRAM ENTRESTAR

Novo Nordisk & ATLATL | December 06, 2022

Novo Nordisk Research Centre China and ATLATL jointly announce the winners of EntreStar program. Hangzhou DNano MetaBio and Modit Medicine stood out among all participants and won the awards. The two winners will be given priority access to one of ATLATL’s nation-wide facilities in China, and a prize of CNY 500K RMB each to pay for the ATLATL facilities and services. They are also entitled to mentoring by relevant experts of Novo Nordisk. There will be no strings attached fo...

Read More
news image

Business Insights, PHARMACY MARKET

COEUS HOLDINGS ANNOUNCES REBRANDING TO REFLECT THE UNIFICATION OF EACH BUSINESS UNIT INTO ONE ENTITY

Businesswire | May 02, 2023

COEUS, a leading healthcare communications, technology, talent, and consulting firm delivering a variety of services and platforms to all stakeholders in the healthcare ecosystem, announced today that it has completed a major rebranding. Following nearly 14 years of both organic growth and acquisitions, all business units have been combined to form one entity: COEUS. Since the company’s inception in 2009, the company sought to build a suite of services capable of providing...

Read More
news image

MARINUS PHARMACEUTICALS EARNS RARE PEDIATRIC DISEASE DESIGNATION FROM FDA FOR GANAXOLONE TREATING CDKL5 DEFICIENCY DISORDER (CDD)

Marinus Pharmaceuticals | July 31, 2020

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, announced today that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) Designation for the company’s product candidate ganaxolone for the treatment of CDKL5 deficiency disorder (CDD), a rare refractory form of pediatric epilepsy. “We are pleased that ganaxolone has received Rare Pediatric Dis...

Read More
news image

PHARMA TECH

VALGENESIS VLMS TO DRIVE DIGITAL TRANSFORMATION FOR LEADING SPANISH PHARMACEUTICAL COMPANY

PR Newswire | January 03, 2024

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a leading Spanish pharmaceutical company selected ValGenesis VLMS – the industry's most trusted electronic validation lifecycle management system – to digitize its corporate validation process. Founded in Spain over eight decades ago, the company focuses on developing over the counter (OTC) drugs and products. Since then, it has grown its product...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us